Delivery Order 36F79723D0188-70RTAC24FR0000061
Award Date
6/13/24
Potential Completion Date
6/12/25
Potential Value
$67K
Funding Federal Agency
Office of the Chief Information Officer
Contracting Federal Agency
Office of Procurement Operations
Awardee
Emergent Devices, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q999 - Medical- Other
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chantilly, VA 20598, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Federal Emergency Management Agency (FEMA) to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, to purchase NARCAN nasal spray in support of FEMA's Environmental, Safety & Health Division operations. The contract has a firm fixed price of $15,921.60 and a completion date of May 31, 2024. Emergent Devices holds multiple federal contracts and grant sub-awards to supply naloxone products, including NARCAN, to various government...
This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The contract is a $934,875.00 delivery order under Emergent Devices' Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs, which runs through August 2028. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has also received other...
This federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, is for the provision of pharmaceuticals, specifically NARCAN nasal spray and other naloxone products, to various U.S. government agencies. The $226,140.00 Firm Fixed Price delivery order was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 and has a completion date of January 13, 2017.
Emergent Devices holds two significant federal contract vehicles - an $11.8...
The Department of Veterans Affairs Veterans Health Administration awarded a $904,465.44 firm fixed price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, holds a Federal Supply Schedule 65 IB contract to provide pharmaceuticals and drugs to VA facilities through 2028. This delivery order was placed against that larger...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the provision of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $452,280.00 and an ultimate completion date of March 10, 2017.
Emergent Devices, Inc. is a subsidiary of Emergent BioSolutions, a multinational specialty biopharmaceutical company. The company holds...
This is a federal contract award to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray to the Department of Veterans Affairs Veterans Health Administration. The $946,261.44 delivery order contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is for a firm fixed price. The naloxone nasal spray is used to rapidly reverse opioid overdoses and treat substance abuse. Emergent Devices has held other contracts to supply this...
This is a federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the delivery of naloxone nasal spray. The contract, valued at $904,465.44, was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The contract is a delivery order under Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which runs through August 2028. Naloxone is a medication used to...
This is a $686,400.00 Delivery Order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical goods. The contract is part of the VA's Federal Supply Schedule 65 IB for Pharmaceuticals and Drugs, which allows the agency to purchase naloxone nasal spray and other hematology-related products from Emergent Devices through August 2028. Emergent Devices has also received sub-awards from state health...
This is a federal contract award to Emergent Devices, Inc., a multinational specialty biopharmaceutical company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract has a potential value of $1,008,582.12 and is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does...
This federal contract award is for the purchase of NARCAN nasal spray by the U.S. Coast Guard, a civilian agency. The $99,908.04 fixed-price purchase order was awarded to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer that specializes in providing medical countermeasures, particularly naloxone products, to various federal agencies.
Emergent Devices holds multiple federal contracts and grant sub-awards to supply NARCAN and other naloxone formulations in support of public...